ArticlePDF Available

Three-Dimensional Echocardiography-Derived Vena Contracta Area at Rest and Its Increase During Exercise Predicts Clinical Outcome in Mild-Moderate Functional Mitral Regurgitation

Authors:
  • Cardiology center Agel, Pardubická krajská nemocnice

Abstract and Figures

Background: This study assessed the independent significance of color Doppler 3-D vena contracta area (VCA) at rest and during exercise as a predictor of clinical outcome in mild-moderate functional mitral regurgitation (FMR). METHODS AND RESULTS: The subjects consisted of 62 patients (age, 68±11 years; 76% male) with chronic systolic heart failure and mild-moderate FMR (<2+/4) at rest. All patients underwent VCA assessment at rest and during semi-supine bicycle exercise. During median follow-up of 17 months (IQR, 13-20 months), 15 patients (24%) had composite endpoint of all-cause death (n=3), heart failure admission (n=11), and heart transplantation (n=1). At baseline, patients with vs. without endpoint had significantly larger VCA at rest (17±6 mm(2)vs. 13±7 mm(2), P=0.002) and at peak exercise (35±16 mm(2)vs. 21±12 mm(2), P<0.001). On Cox regression analysis, large (≥15-mm(2)) resting VCA (HR, 7.6; 95% CI: 1.93-13.02; P=0.004) and large (≥20-mm(2)) exercise-induced increase of VCA (HR, 5.1; 95% CI: 1.39-15.21; P=0.014) were independently associated with composite endpoint. Concomitant presence of large VCA at rest and its large increase during exercise occurred in 53% of patients with, vs. in only 8% without, endpoint (negative predictive value, 86%). Conclusions: The presence of relatively large VCA at rest and its significant increase during exercise is independently associated with adverse clinical outcome in patients with mild-moderate FMR at rest.
Content may be subject to copyright.
Circulation Journal Vol.78, November 2014
Circulation
Journal
Ocial
Journal
of
the
Japanese
Circulation
Society
http://www.j-circ.or.jp
than any single 2-D method.8,9 The prognostic signicance of
VCA at rest and its increase during exercise, however, has not
been investigated. Therefore, the goal of the present study was
threefold: rst, to evaluate the feasibility of VCA to quantify
FMR during bicycle exercise; second, to assess the independent
signicance of VCA at rest and its increase during exercise to
predict clinical outcome; and, third, to compare the 2-D and
3-D methods for assessing FMR at rest and during exercise.
Methods
Patients
The subject group consisted of 78 consecutive patients (age,
67±12 years; 78% male) with chronic systolic heart failure who
were admitted for acute worsening if they fullled the follow-
ing criteria: (1) left ventricular (LV) systolic dysfunction (LV
evere functional mitral regurgitation (FMR) at rest and/or
its signicant increase during exercise have been shown
to be associated with reduced functional capacity and
impaired prognosis.15 In these studies, FMR has been assessed
using 2-dimensional (D) quantitative techniques: proximal iso-
velocity surface (PISA) and pulsed Doppler volumetry. These
methods, however, have several known limitations such as geo-
metric assumptions of a hemispherical regular effective regur-
gitant orice (ERO), underestimation of ERO in FMR, low re-
producibility and indirect measurement of ERO.69 Recently,
color Doppler 3-D echocardiography-derived vena contracta
cross-sectional area (VCA) has emerged as a new method to
assess FMR severity at rest, which allows direct assessment of
ERO without geometric and ow assumptions.813 VCA at rest
has been shown to have higher correlation with the 2-D integra-
tive method or magnetic resonance-derived regurgitant volume
S
Received February 14, 2014; revised manuscript received August 13, 2014; accepted August 17, 2014; released online October 3, 2014
Time for primary review: 24 days
Cardiovascular Center Aalst, OLV Clinic, Aalst (J.V., J.B., M.V., M.P.), Belgium; Institute of Clinical and Experimental Medicine (IKEM),
Prague (M.K., R.K.), Czech Republic
Mailing address: Martin Penicka, MD, PhD, Cardiovascular Center Aalst, OLV-Clinic, Moorselbaan 164, 9300 Aalst, Belgium. E-mail:
martin.penicka@olvz-aalst.be
ISSN-1346-9843 doi: 10.1253/circj.CJ-14-0183
All rights are reserved to the Japanese Circulation Society. For permissions, please e-mail: cj@j-circ.or.jp
Three-Dimensional Echocardiography-Derived Vena
Contracta Area at Rest and Its Increase During
Exercise Predicts Clinical Outcome in Mild-Moderate
Functional Mitral Regurgitation
Jan Vecera, MD; Jozef Bartunek, MD, PhD; Marc Vanderheyden, MD; Martin Kotrc, MD;
Radka Kockova, MD; Martin Penicka, MD, PhD
Background: This study assessed the independent significance of color Doppler 3-D vena contracta area (VCA)
at rest and during exercise as a predictor of clinical outcome in mild-moderate functional mitral regurgitation (FMR).
Methods and Results: The subjects consisted of 62 patients (age, 68±11 years; 76% male) with chronic systolic
heart failure and mild-moderate FMR (<2+/4) at rest. All patients underwent VCA assessment at rest and during
semi-supine bicycle exercise. During median follow-up of 17 months (IQR, 13–20 months), 15 patients (24%) had
composite endpoint of all-cause death (n=3), heart failure admission (n=11), and heart transplantation (n=1). At
baseline, patients with vs. without endpoint had significantly larger VCA at rest (17±6 mm2 vs. 13±7 mm2, P=0.002)
and at peak exercise (35±16 mm2 vs. 21±12 mm2, P<0.001). On Cox regression analysis, large (15-mm2) resting
VCA (HR, 7.6; 95% CI: 1.93–13.02; P=0.004) and large (20-mm2) exercise-induced increase of VCA (HR, 5.1; 95%
CI: 1.39–15.21; P=0.014) were independently associated with composite endpoint. Concomitant presence of large
VCA at rest and its large increase during exercise occurred in 53% of patients with, vs. in only 8% without, endpoint
(negative predictive value, 86%).
Conclusions: The presence of relatively large VCA at rest and its significant increase during exercise is indepen-
dently associated with adverse clinical outcome in patients with mild-moderate FMR at rest. (Circ J 2014; 78:
2741 – 2749)
Key Words: Echocardiography; Exercise; Heart failure; Mitral regurgitation; Prognosis
ORIGINAL ARTICLE
Valvular Heart Disease
Circulation Journal Vol.78, November 2014
2742 VECERA J et al.
system (Vivid E9; GE Medical Systems, Horten, Norway)
equipped with speckle tracking and 3-D color Doppler imag-
ing. All images were stored in digital format for ofine analy-
sis. The mean from at least 3 consecutive beats (5 in atrial -
brillation) was taken for each measurement both at rest and
during exercise. Standard assessment of LV dimensions, LV
volumes and ejection fraction (bi-apical Simpson method), sphe-
ricity index, left atrial volume (bi-apical area-length method)
was performed according to the current recommendations.14
Mitral Valve Deformation
This was assessed in the apical 4-chamber view. The mitral
valve tenting area, coaptation height, anterior and posterior mi-
tral leaet angle were assessed at mid-systole. Mitral annulus
diameter was measured in end-diastole.
Quantication of FMR
In the apical 4-chamber view, full-volume, color Doppler 3-D
loops were recorded during respiration using the 3V-D active
matrix 4-D volume phased array probe using real-time, single-
beat acquisition. The narrowest sector possible was used to
maximize the frame rate.
Average frame rate for the 3-D color Doppler dataset acqui-
sition was 15±1.8 frames/s. This frame rate provides 7–8 frames
per systole at a heart rate of 60 beats/min and 6–7 frames per
systole at a heart rate of 100 beats/min.15 The typical color code
bar setting for the assessment of VCA is similar to the setting
used for the PISA method, with baseline shift downward to the
negative aliasing velocity between 20 and 40 cm/s. The 3-D
color Doppler datasets were analyzed using dedicated software
(EchoPac for PC, GE) as follows: 3-D color Doppler signals
were optimized to distinguish the vena contracta from the prox-
imal ow convergence and a rapidly expanding jet in 2 simul-
taneous 2D-derived perpendicular planes to ensure the best
reproducibility. To identify VCA, the 3-D dataset was rotated
to bisect the regurgitant color jet at the level of leaet coapta-
tion zone perpendicularly to its long axis in 2 orthogonal planes.
The image was cropped along the jet direction to visualize the
cross-sectional area at the level of vena contracta. The VCA
was dened as the high-velocity core of the color spectrum
and to avoid the “color bleeding”, that is, the low-velocity ow
signal in the periphery of the color spectrum. To facilitate de-
lineation of the VCA, the color gain was lowered. In contrast
to low-velocity peripheral ows, the vena contracta ow is less
affected by the color gain adjustments. When reducing gain,
the high intense core of the high-velocity vena contracta ow
is the last to remain. Figure 1 shows examples of the vena con-
tracta ow and low-velocity peripheral ows with the color
code bar setting. The VCA at the closest frame preceding mid-
systole was magnied and traced manually. Usually, this was
the third or fourth systolic frame at rest and the third systolic
frame during peak exercise. Furthermore, 3-D color Doppler
echocardiography-derived vena contracta cross-section length
(VCL) was assessed as the largest diameter of VCA. In the
case of multiple jets, VCA and VCL were calculated as the
sum of the individual VCA and VCL. Figure 2 shows a rep-
resentative VCA tracing in 2 patients with mild-moderate FMR
at rest, 1 with a signicant exercise-induced increase of VCA
(Figures 2A,B) and 1 with a stable small VCA during exercise
(Figures 2C,D). The 2D-derived assessments of FMR includ-
ed the PISA method-derived ERO and vena contracta width.6,7
Statistical Analysis
Data are presented as mean ± SD for continuous variables and
as percentage for categorical variables. The unpaired or paired
ejection fraction <45%) of ischemic or non-ischemic origin; (2)
mild-moderate FMR (<2+/4) at rest on 2-D integrative ap-
proach;6,7 and (3) optimal pharmacological therapy. Patients who
were unable to perform semi-supine exercise, who had acute
coronary syndrome in the previous 30 days, concomitant or-
ganic mitral valve lesions or signicant aortic valve disease were
excluded. The study complied with the Declaration of Helsinki.
The study protocol was approved by the Ethics Committees of
both participating institutions. All patients gave written informed
consent before inclusion in the study.
Study Protocol
After compensation, before discharge all patients underwent
resting and graded, symptom-limited exercise echocardiogra-
phy using a tilting bicycle table allowing continuous echocar-
diography monitoring in the semi-supine position. The initial
workload of 25 W was increased every 2 min by 25 W. Blood
pressure and 12-lead electrocardiography were recorded every
2 min. 2-, 3-D and Doppler echocardiography was performed
at rest and throughout the exercise. The blood sample for N-
terminal of the prohormone B-type natriuretic peptide (NT-
proBNP) was collected prior to echocardiography. Thereafter,
patients were followed up clinically.
Echocardiography
All echocardiography was done using a commercially available
Figure 1. (AD) Individual examples of the vena contracta
cross-sectional area (VCA) with typical color code bare set-
ting. To assess VCA the baseline of the color code bar setting
was shifted downward to the negative aliasing velocity be-
tween 20 and 40 cm/s (upper left corner). To improve delinea-
tion of the vena contracta flow, color gain was reduced to
eliminate peripheral low-velocity signals. When reducing gain
the high intense core of the high-velocity vena contracta flow
is the last to remain.
Circulation Journal Vol.78, November 2014
2743VCA and Outcome in FMR
3.8±2.0 min. An additional 9 patients underwent implantation
of biventricular pacemaker during the index hospitalization and
were excluded. The remaining 62 patients (age, 68±11 years;
76% male) were included in the clinical outcome analysis. Dur-
ing a median follow-up of 17 months (IQR, 13–20 months),
15 patients (24%) reached the composite endpoint (death, n=3;
admission for worsening heart failure, n=11; heart transplanta-
tion, n=1). Follow-up was obtained in all patients.
Baseline and Exercise Characteristics
At baseline, patients with endpoint compared to patients with-
out endpoint had more advanced heart failure as evidenced by
signicantly higher NT-proBNP, wider QRS complex and
reduced tricuspid annular plane systolic excursion (all P<0.05;
Table 1). Moreover, in the 2 years preceding the study inclu-
sion, patients with endpoint were more likely to be admitted
repeatedly for worsening heart failure (P<0.001) than individu-
als without endpoint. Prevalence of cardiac resynchronization
therapy, ischemic cardiomyopathy or atrial brillation was
similar in both groups. E/e’, degree of global LV remodeling
and ejection fraction, and the indices of mitral valve deforma-
tion did not differ between groups (Table 1). Furthermore, the
Student’s t-test and the Pearson correlation coefcient were used
as appropriate. Fisher’s exact test was used to compare cate-
gorical variables in 2×2 contingency tables. Receiver operating
characteristic curves were constructed to assess optimal cut-
off for the VCA to predict clinical outcome and also to com-
pare VCA, VCL and PISA-derived ERO. The endpoint was
dened as a composite of death from any cause, admission for
worsening heart failure and heart transplantation. Independent
predictors of the composite endpoint were identied using the
Cox proportional hazard model and expressed as a hazard ratio
and 95% condence interval. Cumulative survival curves were
derived according to the Kaplan-Meier method, and differ-
ences between curves were analyzed on log-rank statistics. For
all tests, P<0.05 was considered signicant.
Results
Seven patients (9%) had poor echocardiography image quality
at rest and were excluded prior to exercise. In all of the remain-
ing 71 patients (age, 67±12 years; 79% male) the assessment
of VCA was feasible both at rest and during exercise (feasibil-
ity, 91%). The image post-processing time to obtain VCA was
Figure 2. Individual examples of significant exercise-induced increase of vena contracta cross-sectional area (VCA) (A,B) vs. a
stable small VCA (C,D). VCA (white ellipse) was assessed using manual planimetry at the closest frame preceding mid-systole.
Care was taken to circle the central area of the high-velocity flow while avoiding the low-velocity color flow signals at the periphery.
The first image from the left shows raw color spectrum without delineating line to illustrate this technique. Vena contracta cross-
section length (VCL) was measured as the maximum VCA diameter. In the first patient (A,B), a relatively large ellipsoid VCA was
observed at rest (A) despite the small color-coded regurgitant jet area and “mild” appearance of functional mitral regurgitation
(FMR). Figure 2B shows significant increase in VCA corresponding to significant FMR during low-load exercise (50 W). It is note-
worthy that proximal isovelocity surface (PISA)-derived effective regurgitant orifice (ERO; B, green circle) showed smaller increase,
suggesting underestimation of ERO by the PISA method. Figures 2C,D shows an example of a patient with the small circular VCA
both at rest and during exercise, respectively, reflecting stable mild-moderate FMR.
Circulation Journal Vol.78, November 2014
2744 VECERA J et al.
patients with endpoint but in only 8% of patients without end-
point (negative predictive value, 86%). VCL at rest (area under
the curve [AUC]=0.68), VCL at peak exercise (AUC=0.73) and
exercise-induced increase in PISA-derived ERO (AUC=0.60)
had lower accuracy. On Cox regression analysis, resting VCA
15 mm2, its 20-mm2 exercise-induced increase, and VCL
13 mm at peak exercise were identied as the only indepen-
dent predictors of composite endpoint (Table 2). The patients
with VCA 15 mm2 or VCA increase 20 mm2 had worse
prognosis on Kaplan-Meier analysis (Figure 4).
2-D vs. 3-D Indices for Assessment of FMR
At rest, a prognostic ERO (20 mm2) was observed in 18 patients
(29%) using the 3-D VCA method but in no patients using the
2-D PISA method (Table 1). A total of 26 patients (42%) had
large 3-D VCL (7 mm) suggesting signicant FMR at rest,
while no patients had wide 2-D vena contracta. Patients with
VCA 20 mm2 or VCL 7 mm had higher occurrence of com-
posite endpoint (8/15 vs. 10/47, P=0.02 for VCA, or 10/15 vs.
16/47, P=0.04 for VCL). At peak exercise, a total of 18 patients
(29%) had large (20-mm2) exercise-induced increase in VCA,
and a total of 15 (24%) had large (13-mm2) exercise-induced
increase in PISA-derived ERO. Figure 5 shows VCA and
PISA-derived ERO at rest and during peak exercise in patients
with endpoint. Both VCA and PISA-derived ERO increased
endpoint group had a signicantly larger VCA (P=0.002),
VCL (P=0.02) and a higher prevalence of large (20-mm2)
“prognostic” VCA (P=0.02) at rest than patients without end-
point (Table 1). In contrast, out of the 2D-derived indices,
only PISA method-derived ERO tended to be larger (P=0.06)
in patients with vs. without endpoint, while the vena contracta
width was similar. No patients had prognostic PISA-derived
ERO (20 mm2). At peak exercise (Table 1), the endpoint group
had a signicantly lower peak exercise load and systolic blood
pressure (both P<0.01) compared with the group without end-
point. Reversible myocardial ischemia was not observed in any
of the patients. The indices of LV remodeling and ejection frac-
tion were similar. Both groups had signicant rest-to-exercise
increase in VCA, VCL, PISA-derived ERO and vena contracta
width (all P<0.01), but signicantly larger VCA, VCL and
vena contracta width (all P<0.01), and slightly larger PISA-
derived ERO (P=0.07) were observed in the endpoint group.
Predictors of Composite Endpoint
Resting VCA and its increase were better predictors for the
composite endpoint than PISA ERO increase (Figure 3). Resting
VCA with a cut-off 15 mm2 and its increase (cut-off 20 mm2)
at peak exercise had the highest accuracy for predicting the
composite endpoint. Concomitant presence of large VCA at rest
and its signicant increase during exercise occurred in 53% of
Table 1. Clinical and Echocardiography Characteristics
Endpoint (+) (n=15) Endpoint (–) (n=47) P-value
Age (years) 65±16 68±9
  
 
0.36
    
Sex (% female) 20 17
 
1.0
      
Diabetes mellitus 4 (27) 11 (23)
 
1.0
      
Coronary artery disease 9 (60) 25 (53)
 
0.77
    
ACE/ATII inhibitors 14 (97) 44 (94)
 
1.0
      
β-blockers 12 (80) 33 (72)
 
0.74
    
Spironolactone 12 (80) 30 (64)
 
0.35
    
Loop diuretics 14 (97) 36 (76)
 
0.26
    
NYHA class 2.5±0.5 2.0±0.6
 
0.09
    
NT-proBNP (pg/ml) 2,180 (1,548–7,100) 1,400 (546–2,856)
 
0.02
    
Hospitalization for worsening HF in preceding 2 years 12 (80) 20 (43)
 
0.017
  
≥2 hospitalizations for worsening HF in preceding 2 years 8 (53) 2 (4) <0.0001
Glomerular filtration rate (ml/min) 61±19 60±14
 
0.95
    
Atrial fibrillation 7 (47) 16 (34)
 
0.54
    
QRS width (ms) 143±33
  
123±33
  
 
0.031
  
CRT 4 (27) 5 (11)
 
0.2
      
E/e’ 16.3±6.4
  
13.0±7.5
  
 
0.14
    
Mitral valve tenting area (cm2) 1.9±1.0 1.6±0.7
 
0.22
    
Mitral valve coaptation height (mm) 8±4 7±3
 
0.12
    
TAPSE (mm) 15.5±3.1
  
17.8±4.0
  
 
0.047
  
Exercise tolerance (W) 52±20 81±38
 
0.007
  
Heart rate (beats/min)
Rest 69±16 72±15
 
0.55
    
Exercise
 
96±27
 
103±23
  
 
0.38
    
Systolic blood pressure (mmHg)
Rest 105±17
  
118±19
  
 
0.021
  
Exercise
 
126±20
  
 
146±23
  
 
0.004
  
LV EDVI (ml/m2)
Rest 102±54
  
90±24
 
0.25
    
Exercise 109±18
  
90±26
 
0.06
    
(Table 1 continued the next page.)
Circulation Journal Vol.78, November 2014
2745VCA and Outcome in FMR
without endpoint (9/15 vs. 9/47, P=0.007). In contrast, the
percentage of patients with 13-mm2 increase in PISA-derived
ERO was similar between the groups (6/15 vs. 9/47, P=0.16;
Table 1).
signicantly (both P<0.01), but the rest-to-peak exercise dif-
ference in VCA was signicantly larger than the difference
in PISA-derived ERO (18±10 mm2 vs. 9±7 mm2, P<0.001;
Figure 5). A signicantly higher proportion of patients with
endpoint had 20-mm2 increase in VCA compared to patients
Endpoint (+) (n=15) Endpoint (–) (n=47) P-value
LV ESVI (ml/m2)
Rest 75±47 64±19
 
0.62
    
Exercise 78±22
 
60±27
 
0.08
    
LV EF (%)
Rest 29±8
  
29±8
  
 
0.46
    
Exercise 30±8
  
 
33±10
 
0.12
    
LV sphericity index
Rest 1.52±0.17 1.52±0.16
 
0.32
    
Exercise 1.58±0.20 1.56±0.21
 
0.54
    
Peak TR gradient (mmHg)
Rest 21±7
  
23±6
  
 
0.42
    
Exercise
 
50±8
  
 
45±9
  
 
0.056
  
VCA (3-D) (mm2)
Rest 17±6
  
13±7
  
 
0.002
  
Exercise
 
35±16
 
21±12<0.001
  
Rest VCA ≥20 mm2 8 (53) 10 (21)
 
0.02
    
Exercise-induced VCA increase ≥20 mm2 9 (60) 9 (19)
 
0.007
  
Exercise-induced VCA increase (mm2) 17±13 8±10
 
0.009
  
VCL (3-D) (mm)
Rest 7.0±2.9 5.1±2.5
 
0.017
  
Exercise
 
12.9±6.7
  
 
8.1±4.6
 
0.002
  
ERO (2-D PISA) (mm2)
Rest 11±5
  
8±5
 
0.058
  
Exercise
 
20±9
  
 
14±10
 
0.07
    
Rest ERO ≥20 mm20 0 NA
Exercise-induced ERO increase ≥13 mm2 6 (40) 9 (19)
 
0.16
    
Vena contracta width (2-D) (mm)
Rest 3.3±0.7 2.9±1.3
 
0.2
      
Exercise
 
5.3±2.3
 
3.9±1.6
 
0.008
  
Data given as mean ± SD, n (%) or median (IQR). *P<0.05, P<0.01, P<0.001 rest vs. exercise. ACE/ATII, angiotensin-converting enzyme/
angiotensin II; CRT, cardiac resynchronization therapy; D, dimensional; EF, ejection fraction; EDVI, end-diastolic volume index; ERO, effective
regurgitant orifice; ESVI, end-systolic volume index; HF, heart failure; LV, left ventricular; NT-proBNP, N-terminal of the prohormone B-type
natriuretic peptide; NYHA, New York Heart Association; PISA, proximal isovelocity surface; TAPSE, tricuspid annular plane systolic excursion;
TR, tricuspid regurgitation; VCA, vena contracta cross-sectional area; VCL, vena contracta length.
Figure 3. Accuracy of vena contracta cross-sectional area (VCA) at rest, exercise-induced increase in VCA and in proximal
isovelocity surface (PISA)-derived effective regurgitant orifice (ERO) to predict the composite endpoint. AUC, area under the curve;
Sp, specificity; Ss, sensitivity.
Circulation Journal Vol.78, November 2014
2746 VECERA J et al.
(n=10) and in atrial brillation (n=10) from recorded images.
In patients with sinus rhythm, the intraobserver and interob-
server variability was 7% and 9% at rest, and 8% and 10%
during exercise, respectively. In patients with atrial brillation,
the intraobserver and interobserver variability was 10% and
14% at rest, and 12% and 15% during exercise, respectively.
Discussion
The present ndings can be summarized as follows. First, the
assessment of VCA during bicycle exercise is highly feasible
and reproducible. Second, both VCA at rest and its increase
during exercise are independent predictors of clinical outcome.
VCA at rest has high sensitivity, while its exercise-induced
increase has high specicity for identifying patients with ad-
verse clinical outcome. Third, the assessment of VCA seems
to be highly sensitive to track exercise-induced changes in FMR,
while the PISA method underestimated ERO both at rest and
during exercise.
Large VCA and Small PISA-Derived ERO During Peak
Exercise
This analysis included all 71 patients (age, 67±12 years; 79%
male) with good image quality both at rest and during exer-
cise. Of the 24 patients with signicant (20-mm2) increase in
VCA only 14 (58%) had signicant (13-mm2) increase of
PISA-derived ERO. A subgroup of patients, in whom the PISA
method failed to identify exercise-induced signicant FMR,
had signicantly higher coaptation height and posterior leaet
angle at rest and during exercise than patients in whom PISA
correctly identied exercise-induced FMR (Table 3). In con-
trast, both subgroups had similar global echocardiography
characteristics and VCA at peak exercise. Of note, the exer-
cise capacity was similar in both PISA subgroups, but was
signicantly lower in patients without exercise-induced in-
crease in VCA.
Reproducibility
Reproducibility for VCA both at rest and during exercise was
assessed in 20 randomly selected patients in sinus rhythm
Table 2. Independent Predictors of Composite Endpoint
Univariate Multivariate
HR (95% CI) P-value HR (95% CI) P-value
Age 0.99 (0.95–1.03)
 
0.69
  
NYHA class 3.1 (1.16–8.33)
 
0.024
NT-proBNP 1.0 (1.00–1.00)
 
0.07
  
QRS duration 1.0 (0.99–1.03)
 
0.09
  
LV EF 0.97 (0.92–1.05)
 
0.45
  
TAPSE 0.86 (0.73–1.00)
 
0.054
Exercise-induced PISA-derived ERO increase ≥13 mm21.13 (0.10–1.26)
 
0.064
VCL at rest ≥7 mm 1.32
 
0.024 1.16 (0.86–11.89) 0.083
VCL at peak exercise ≥13 mm 7.40
 
0.002 5.85 (1.67–14.09) 0.009
Resting VCA ≥15 mm28.11 <0.001 7.60 (1.93–13.02) 0.004
Exercise-induced VCA increase ≥20 mm26.33
 
0.004 5.10 (1.39–15.21) 0.014
CI, confidence interval; HR, hazard ratio. Other abbreviations as in Table 1.
Figure 4. Kaplan-Meier estimates of the time to death resulting from any cause, admissions for worsening heart failure or heart
transplantation. Patients were divided into 2 groups according to (A) presence or absence of vena contracta cross-sectional area
(VCA) 15 mm2 at rest, or (B) presence or absence of exercise-induced increase of VCA 20 mm2 at peak exercise.
Circulation Journal Vol.78, November 2014
2747VCA and Outcome in FMR
ERO in patients with ischemic LV dysfunction.19 The exercise-
induced increase in PISA-derived ERO 13 mm2 has been as-
sociated with adverse outcome.3,4 Corroborating this nding,
in the present study, patients with endpoint had signicantly
larger VCA during exercise than patients without endpoint.
Moreover, the exercise-induced increase in VCA 20 mm2 has
been identied as an independent predictor of composite end-
point. In contrast to the previous studies, exercise-induced
increase in PISA ERO did not predict outcome in the present
study. The reasons may be several. In the present study, only
patients with mild-moderate FMR at rest were included. In
contrast, the Lancellotti et al studies enrolled patients with high-
er degrees of FMR at rest.3,4 In the present study, both VCA
and the PISA-derived ERO increased signicantly, but the rest-
to-peak exercise difference in VCA was signicantly larger
than the difference in PISA-derived ERO. Furthermore, the
exercise-induced signicant increase of PISA-derived ERO
(>13 mm2) identied only 10 out of 24 patients (58%) with
signicant increase in VCA (>20 mm2). The underestimation
of ERO by the PISA method was observed predominantly in
patients with severe distortion of the mitral valve geometry,
implying highly irregular ERO shape. Finally, direct compari-
son of VCA and PISA-derived ERO was not possible, because
VCA reects the anatomical surface of the regurgitant orice,
while PISA-derived ERO represents the physiological param-
eter based on hydrodynamic theory of ow converging towards
a restricted orice. The limitation of a single 2-D measurement
in the setting of non-circular ERO may partly be compensated
for by using multiple 2-D measurements in different echocar-
diography planes. This approach, however, may substantially
increase the data acquisition time, which may be of particular
importance during exercise, when the time window to obtain
images is limited. In contrast, a single recording in 1 echocar-
diography view is needed to acquire color Doppler 3-D data-
set for the VCA assessment.
Study Limitations
In the current study, a single-beat (live) 3-D color Doppler ac-
Feasibility and Reproducibility
Several studies have demonstrated high feasibility and repro-
ducibility for VCA assessment at rest.813 The current study
extends these ndings by showing high feasibility (91%) and
reproducibility of the VCA measurement also during low-grade
exercise, with a short image post-processing time <5 min. The
feasibility of color Doppler 3-D echocardiography-derived VCA
assessment has been related to the 2-D echocardiography image
quality at rest. In all the patients with acceptable 2-D image
quality at rest, the assessment of VCA was feasible both at rest
and during exercise. Similarly, the intra- and interobserver
variability of the VCA assessment was low (<10%) and not
signicantly affected by bicycle exercise.
VCA at Rest and Clinical Outcome
Previous studies have demonstrated that presence of resting
FMR in patients after myocardial infarction or with ischemic
LV dysfunction is associated with increased mortality, increased
admission rate for worsening heart failure and reduced func-
tional capacity.14 In those studies, the cut-off for ERO 20 mm2,
assessed using 2-D PISA or pulsed Doppler volumetry, identi-
ed individuals with the worst prognosis. The present study
included patients with mild-moderate FMR at rest assessed
using the 2-D integrative approach.6,7 In line with the inclusion
criteria, in the current study, all patients had PISA-derived ERO
<20 mm2 at rest, and PISA-derived ERO did not predict out-
come. In contrast, prognostic VCA 20 mm2 at rest was observed
in 29% of the present subjects, and its presence was associated
with signicantly higher occurrence of composite endpoint.
Moreover, VCA 15 mm2 emerged as an independent predic-
tor of outcome. Finally, a total of 26 patients (42%) had large
3-D VCL (7 mm) suggesting signicant FMR at rest, while
no patients had wide 2-D vena contracta. This suggests that
the presence of relatively large ellipsoid VCA may be a mark-
er of signicant FMR with adverse outcome, despite grading
of FMR as “mild-moderate” using 2-D PISA or vena contracta
width. This also suggests that the 2D-derived approach may
underestimate severity of FMR in some patients. Currently,
the 2-D integrative method is the recommended approach to
assess severity of FMR.6,7 This method integrates several 2D-
based indices to circumvent the limitations of each of these
techniques. Recent studies have investigated the color Doppler
3-D echocardiography approach for FMR quantication by
direct measurement of ERO using VCA.813 VCA at rest has
been shown to have a higher correlation with the 2-D integra-
tive method or magnetic resonance-derived regurgitant volume
than any single 2-D method.8,9 In contrast, in patients with
FMR, the PISA method signicantly underestimated ERO by
27% due to the geometric and ow assumptions. The irregular
hemi-elliptical shape of ERO is relatively common in FMR.16
Asymmetric ERO leads to underestimation of FMR severity
by commonly used 2-D methods, such as PISA or vena con-
tracta width.813,16,17 In contrast, the 3-D technique used in the
current study allows direct visualization of ERO with precise
assessment of its area and longest diameter and gives better
results as reected by AUC for VCA, ERO (PISA) and VCA
increase during exercise (Figure 3).
VCA During Exercise and Clinical Outcome
Distinction of dynamic severe from stable mild FMR in pa-
tients with systolic LV dysfunction and mild-moderate FMR
at rest is critical, because the former are associated with re-
duced survival.3,4,18 The landmark studies of Lancellotti et al
showed the wide range of exercise-induced changes in the
PISA method- or pulsed Doppler volumetric method-derived
Figure 5. Comparison between proximal isovelocity surface
(PISA)-derived effective regurgitant orifice (ERO) and 3-D
vena contracta cross-sectional area (VCA) at rest and during
exercise in patients with the composite endpoint. P<0.01,
P<0.001 rest vs. exercise.
Circulation Journal Vol.78, November 2014
2748 VECERA J et al.
study, single-beat data acquisition was used for a patient serving
as his own control between rest and exercise. From the clinical
point of view, it is currently unknown whether correction of
FMR with signicant increase during exercise may change the
prognosis, especially in such high-risk patients, but emerging
new techniques such as Mitraclip might be of use in these
cases.20
Conclusions
The present study extends ndings of the previous studies by
showing that VCA at rest and its increase during exercise are
independent predictors of clinical outcome. In patients with
mild-moderate FMR at rest, VCA enabled identication of in-
dividuals with adverse clinical outcome, who would have been
missed using the 2-D-derived indices. The assessment of VCA
quisition for the assessment of VCA was used. The single-beat
recording has relatively lower temporal resolution than the
multiple-beat acquisition. In this study, the average number of
frames per systole was between 6 and 8. Supine bicycle exer-
cise is associated with shortening of diastole and only minor
changes in the duration of systole,15 therefore the heart rate
achieved at peak exercise (average 100 beats/min) was not as-
sociated with the signicant decrease in number of frames per
systole. Single-beat compared to multiple-beat acquisition has
several distinct advantages in patients with heart failure under-
going exercise. These severely ill patients often have irregular
heart rate due to atrial brillation, or frequent premature beats.
These individuals are not able to hold their breath during ex-
ercise. Irregular heart rate and absence of apnea lead to stitching
and respiratory artifacts that hamper the accuracy of multiple-
beat-derived VCA during exercise. Therefore, in the present
Table 3. Echocardiography Characteristics vs. PISA ERO Increase
VCA increase (≥20 mm2) (n=24)
PISA ERO increase
≥13 mm2 (n=14)
PISA ERO increase
<13 mm2 (n=10) P-value
Effective regurgitant orifice (2-D PISA) (mm2)
Rest 10±4
 
11±4
 
 
0.4
    
Exercise 27±618±5<0.001
VCA (3-D) (mm2)
Rest 17±6
 
18±5
 
 
0.91
  
Exercise 44±640±7
 
0.16
  
VCL (3-D) (mm)
Rest 7.6±2.2
 
7.8±2.1
 
 
0.8
    
Exercise 16.1±3.214.4±2.2
 
0.15
  
LV EDVI (ml/m2)
Rest 95±29
 
117±66
 
 
0.29
  
Exercise 104±31
 
122±61
 
 
0.37
  
LV ESVI (ml/m2)
Rest 70±27
 
91±55
 
 
0.25
  
Exercise 74±32
 
92±55
 
 
0.38
  
LV EF (%)
Rest 27±7
 
23±6
 
 
0.18
  
Exercise 29±10
 
27±7
 
 
0.44
  
LV sphericity index
Rest 1.56±0.13
 
1.50±0.23
 
 
0.45
  
Exercise 1.46±0.18* 1.50±0.16
 
 
0.58
  
E/e’
Rest 15.0±5.8
 
19.8±8.8
 
 
0.12
  
Exercise 21.2±18.0 25.2±11.9
 
0.58
  
Mitral valve tenting area (cm2)
Rest 1.6±0.7
 
2.2±1.2
 
 
0.15
  
Exercise 2.4±1.0 3.2±1.3
 
0.11
  
Mitral valve coaptation height (mm)
Rest 6.8±2.9
 
9.8±3.9
 
 
0.04
  
Exercise 8.9±3.912.5±3.3
 
0.03
  
Anterior leaflet angle (°)
Rest 19±10
 
27±14
 
 
0.1
    
Exercise 27±11 35±13
 
 
0.12
  
Posterior leaflet angle (°)
Rest 23±11
 
33±9
 
 
0.04
  
Exercise 29±13* 41±7
 
0.011
Exercise capacity (W) 55±31
 
46±19
 
 
0.41
  
*P<0.05, P<0.01, P<0.001 rest vs. exercise. Abbreviations as in Table 1.
Circulation Journal Vol.78, November 2014
2749VCA and Outcome in FMR
8. Marsan NA, Westenberg JJ, Ypenburg C, Delgado V, van Bommel
RJ, Roes SD, et al. Quantication of functional mitral regurgitation
by real-time 3D echocardiography: Comparison with 3D velocity-
encoded cardiac magnetic resonance. JACC Cardiovasc Imaging 2009;
2: 1245 – 1252.
9. Zeng X, Levine RA, Hua L, Morris EL, Kang Y, Flaherty M, et al.
Diagnostic value of vena contracta area in the quantication of mitral
regurgitation severity by color Doppler 3D echocardiography. Circ
Cardiovasc Imaging 2011; 4: 506 – 513.
10. Iwakura K, Ito H, Kawano S, Okamura A, Kurotobi T, Date M, et al.
Comparison of orice area by transthoracic three-dimensional Doppler
echocardiography versus proximal isovelocity surface area (PISA)
method for assessment of mitral regurgitation. Am J Cardiol 2006;
97: 1630 – 1637.
11. Little SH, Pirat B, Kumar R, Igo SR, McCulloch M, Hartley CJ, et
al. Three-dimensional color Doppler echocardiography for direct
measurement of vena contracta area in mitral regurgitation: In vitro
validation and clinical experience. JACC Cardiovasc Imaging 2008;
1: 695 – 704.
12. Yosefy C, Hung J, Chua S, Vaturi M, Ton-Nu TT, Handschumacher
MD, et al. Direct measurement of vena contracta area by real-time
3-dimensional echocardiography for assessing severity of mitral re-
gurgitation. Am J Cardiol 2009; 104: 978 – 983.
13. Shanks M, Siebelink HM, Delgado V, van de Veire NR, Ng AC,
Sieders A, et al. Quantitative assessment of mitral regurgitation:
Comparison between three-dimensional transesophageal echocar-
diography and magnetic resonance imaging. Circ Cardiovasc Imag-
ing 2010; 3: 694 – 700.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E,
Pellikka PA, et al. Recommendations for chamber quantication. Eur
J Echocardiogr 2006; 7: 79 – 108.
15. Chung CS, Karamanoglu M, Kovacs SJ. Duration of diastole and its
phases as a function of heart rate during supine bicycle exercise. Am
J Physiol Heart Circ Physiol 2004; 287: H2003 – H2008.
16. Grayburn PA, Weissman NJ, Zamorano JL. Quantitation of mitral
regurgitation. Circulation 2012; 126: 2005 – 2017.
17. Kahlert P, Plicht B, Schenk IM, Janosi RA, Erbel R, Buck T. Direct
assessment of size and shape of noncircular vena contracta area in
functional versus organic mitral regurgitation using real-time three-
dimensional echocardiography. J Am Soc Echocardiogr 2008; 21:
912 – 921.
18. Pierard LA, Lancellotti P. The role of ischemic mitral regurgitation
in the pathogenesis of acute pulmonary edema. N Engl J Med 2004;
351: 1627 – 1634.
19. Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced
changes in mitral regurgitation in patients with coronary artery disease
and left ventricular dysfunction. J Am Coll Cardiol 2003; 42: 1921 –
1928.
20. Alegria-Barrero E, Chan PH, Paulo M, Duncan A, Price S, Moat N,
et al. Edge-to-edge percutaneous repair of severe mitral regurgitation:
State-of-the-art for Mitraclip® implantation. Circ J 2012; 76: 801 –
808.
during exercise is feasible, reproducible and reliable for track-
ing the exercise-induced changes in ERO. VCA assessment is
based on 1 single measurement of directly visualized ERO, thus
avoiding geometric and ow assumptions. This may be of value
during exercise because the 2-D indices are all indirect, under-
estimate ERO in FMR and require multiple sampling in dif-
ferent imaging planes. Furthermore, identication of resting
predictors of adverse outcome in patients with mild-moderate
FMR at rest may be of potential importance, because the ex-
pertise and tilted bicycle table used for exercise echocardiog-
raphy are not widely available. These ndings advocate inte-
gration of the VCA method into the current approaches for
assessing FMR.
Disclosures
None.
Funding Sources
None.
References
1. Grigioni F, Detaint D, Avierinos JF, Scott C, Tajik J, Enriquez-Sarano
M. Contribution of ischemic mitral regurgitation to congestive heart
failure after myocardial infarction. J Am Coll Cardiol 2005; 45: 260 –
267.
2. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Isch-
emic mitral regurgitation: Long-term outcome and prognostic impli-
cations with quantitative Doppler assessment. Circulation 2001; 103:
1759 – 1764.
3. Lancellotti P, Gerard PL, Pierard LA. Long-term outcome of patients
with heart failure and dynamic functional mitral regurgitation. Eur
Heart J 2005; 26: 1528 – 1532.
4. Lancellotti P, Troisfontaines P, Toussaint AC, Pierard LA. Prognostic
importance of exercise-induced changes in mitral regurgitation in
patients with chronic ischemic left ventricular dysfunction. Circula-
tion 2003; 108: 1713 – 1717.
5. Boyd JH. Ischemic mitral regurgitation. Circ J 2013; 77: 1952 – 1956.
6. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen
T, Pierard LA, et al. Recommendations for the echocardiographic
assessment of native valvular regurgitation: An executive summary
from the European Association of Cardiovascular Imaging. Eur Heart
J Cardiovasc Imaging 2013; 14: 611 – 644.
7. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD,
Levine RA, et al. Recommendations for evaluation of the severity of
native valvular regurgitation with two-dimensional and Doppler echo-
cardiography. J Am Soc Echocardiogr 2003; 16: 777 – 802.
... Several promising imaging approaches to assess AR or its impact on LV structure and function have emerged recently [13][14][15][16][17][18][19][20]. For instance, three-dimensional (3D) ECHO-or magnetic resonance (MRI)-derived evaluation of AR severity may increase the accuracy of AR classification [16,19,20]. ...
... Several promising imaging approaches to assess AR or its impact on LV structure and function have emerged recently [13][14][15][16][17][18][19][20]. For instance, three-dimensional (3D) ECHO-or magnetic resonance (MRI)-derived evaluation of AR severity may increase the accuracy of AR classification [16,19,20]. Assessment of LV myocardial fibrosis, strain or work may be more sensitive than LV diameters or ejection fraction (LVEF) to detect irreversible myocardial damage at an early stage [13][14][15]17,18,21]. ...
... Low velocity peripheral signals of the color spectrum were rejected. The VCA was defined as the high velocity core of the color spectrum [20]. overfitting and to avoid combining mutually dependent variables in one analysis. ...
Article
Full-text available
Background: Determining the value of new imaging markers to predict aortic valve (AV) surgery in asymptomatic patients with severe aortic regurgitation (AR) in a prospective, observational, multicenter study. Methods: Consecutive patients with chronic severe AR were enrolled between 2015–2018. Baseline examination included echocardiography (ECHO) with 2- and 3-dimensional (2D and 3D) vena contracta area (VCA), and magnetic resonance imaging (MRI) with regurgitant volume (RV) and fraction (RF) analyzed in CoreLab. Results: The mean follow-up was 587 days (interquartile range (IQR) 296–901) in a total of 104 patients. Twenty patients underwent AV surgery. Baseline clinical and laboratory data did not differ between surgically and medically treated patients. Surgically treated patients had larger left ventricular (LV) dimension, end-diastolic volume (all p < 0.05), and the LV ejection fraction was similar. The surgical group showed higher prevalence of severe AR (70% vs. 40%, p = 0.02). Out of all imaging markers 3D VCA, MRI-derived RV and RF were identified as the strongest independent predictors of AV surgery (all p < 0.001). Conclusions: Parameters related to LV morphology and function showed moderate accuracy to identify patients in need of early AV surgery at the early stage of the disease. 3D ECHO-derived VCA and MRI-derived RV and RF showed high accuracy and excellent sensitivity to identify patients in need of early surgery.
... Whereas, according to some authors Krishnaswamy et al. 9 ; Lee et al., 10 Vecera et al., 11 The posteromedial and anterolateral portions of the mitral valve annulus are where mitral PVLs are most common. Table 3. Showed association between sites detected by 2D and 3D. ...
... Variability of secondary MR makes clinical assessment based on one ECHO imaging insufficient [17]. The FMR mechanism is heterogenous and there is no single strong parameter to predict precisely the severity of FMR [10], for instance the increase in preload deteriorates FMR and can induce congestive heart failure [17][18][19]. Such conditions are not permanent and the decision about the type of valve surgery is usually based just on one ECHO report. ...
Article
Full-text available
Background: Referral and admission echocardiography (ECHO) in patients scheduled for aortic valve replacement (AVR) with aortic stenosis (AS) may differ in the assessment of moderate functional mitral regurgitation (FMR). Aims: Our study was to determine the truly moderate-FMR and evaluate its impact on survival. Methods: We conducted an observational study of patients referred for AVR with AS and up to moderate FMR, between 2014 and 2019. Patients were divided into three groups: (1) no/mild (N-FMR); (2) moderate-FMR on one ECHO (either at referral or admission) termed incidental (I-FMR); (3) moderate FMR in two studies (both at referral and admission) termed permanent (PM-FMR). Results: The referral and admission assessment were performed median 35 days apart. Of the 679 elective patients who underwent elective isolated AVR, 516 patients had N-FMR, 102 patients had I-FMR, and 61 patients had PM-FMR. Median follow-up was 46 months (22.5-58.5); max 73.3. 30-day mortality was 2.5% vs. 1% vs. 8.2% (N-FMR vs. I-FMR vs. PM-FMR, respectively; P = 0.01). Five-year survival was 84.1% in N-FMR vs. 88.5% in I-FMR vs. 60.6% in PM-FMR group, where was the lowest (P <0.001). In multivariable modeling PM-FMR increased mortality (hazard ratio [HR], 1.88 [1.05-3.37]; P = 0.03). The I-FMR had no effect on mortality (HR, 0.67 [0.32-1.37]; P = 0.28). Five-year survival after excluding 30-day mortality was 86.3% vs. 89.4% vs. 66.0%; (N-FMR vs. I-FMR vs. PM-FMR, respectively; P = 0.02). The PM-FMR increased late mortality (HR, 2.17 [1.14-4.15]; P = 0.01). Conclusions: In patients undergoing isolated AVR for AS, the presence of permanent moderate FMR significantly impacts 30-day and mid-term survival.
... According to pre-defined parameters [ Supplementary Figure 2], 15 patients (45%) with DMR and 24 patients (40%) with FMR revealed a marked increase in MR severity (EROA > 10 mm 2 , RVol > 15 mL) during handgrip exercise, irrespective of MR severity at rest. These data foster previous results from studies reporting dynamic MR during exercise in one-third of patients with DMR [17] and in 30%-50% of cases with FMR, both ischemic and non-ischemic etiology [18][19][20][21] . Increasing MR severity during handgrip exercise is exaggerated by the hemodynamic response [22] , which mainly imposes pressure load on the left ventricle due to an increase in systemic vascular resistance, whereas dynamic exercise predominately results in volume overload [23] . ...
Article
Full-text available
Aim: To investigate whether patients with symptomatic heart failure and exercise-induced dynamic severe mitral regurgitation (MR) benefit from percutaneous mitral valve repair (PMVR). Methods: We included patients who underwent PMVR with the MitraClip system in an all-comers observational study. Handgrip echocardiography was performed in patients with a discrepancy between symptoms and echocardiographic findings at rest, giving rise to the suspicion of an exercise-induced increase in MR severity. The primary endpoint of the study was a composite of all-cause mortality or admission for heart failure at 1-year follow-up. The secondary endpoint was the reduction in NYHA functional class. Results: Two hundred twenty-one patients who underwent MitraClip implantation were included. Ninety-three patients with moderate to severe MR at rest received handgrip echocardiography prior to PMVR. The remaining 128 patients presented with severe MR at rest, making exercise echocardiography unnecessary. Handgrip exercise led to an increase in MR severity in 81% of patients with moderate MR at rest, irrespective of the subtype of MR. Following PMVR, patients with dynamic severe MR experienced comparable clinical improvement as patients with severe MR already at rest: During 1-year follow-up, 37 patients died, and 71 patients were re-admitted to the hospital because of heart failure. In this regard, 13 patients (30%) with dynamic severe MR experienced the combined endpoint, while 72 patients (43%) with severe MR at rest did as well (P = 0.121). Moreover, the majority of patients with dynamic severe MR similar to patients with severe MR at rest experienced clinical improvement from NYHA class III/IV to I/II (59% vs. 56%; P = 0.566). Conclusion: The data presented provide evidence of a clinical benefit from PMVR using MitraClip in patients with moderate MR at rest who display exercise-induced increases in MR severity during handgrip exercise.
... Several studies have showed high feasibility and reproducibility for VCA assessment at rest (26). VCA at rest has high sensitivity while its exercise-induced increase has high specificity for identifying patients with the adverse clinical outcome (27). Also, the assessments of VCA seems to be highly sensitive to track exercise-induced changes in functional MR, while the PISA method underestimated EROA both at rest and during exercise. ...
Article
Full-text available
Background: Mitral Regurgitation (MR) is usually insidious due to progressive remodeling of atrial and left ventricle (LV). In secondary MR, the mitral valve apparatus are structurally normal but dysfunctional because of ischemic or non-ischemic cardiomyopathy. The aim of this study was to identify echocardiographic MR variables associated with 6 Minute Walk (6MW) exercise in patients with non-ischemic cardiomyopathy. Methods: This prospective study involved 81 consecutive patients with clinically stable non-ischemic LV dysfunction (ejection fraction lower than 40%) and at least mild MR who were able to perform symptom limited 6MW exercise. All the patients underwent standard Doppler echocardiography examination and each patient had a recent normal coronary angiography. All patients were evaluated for their functional capacities, stratified by New York Heart Association classification and underwent echocardiography evaluation before 6MW aerobic exercise and after 6 months. The severity of regurgitation established by a comprehensive evaluation of color and conventional Doppler criteria. Results: Proximal isovelocity surface area (PISA) decreased significantly from 42 (17-64) to 29 (12-47) mm2 (p<0.001). Regurgitant orifice area calculated by the PISA method decreased significantly from 27 (16-41) to 20 (10-34) mm2 (p<0.001). The regurgitant volume calculated by the quantitative Doppler method, and vena contracta width decreased significantly from 0.43 (0.200.60) to 0.40 (0.20-0.50) cm (p<0.001). There was no significance difference at baseline and after six months for LV end diastolic diameter and diastolic function parameters. Conclusion: We conclude that a simple, easily reproducible 6MW exercise might supplement the assessment of the grade of MR in secondary MR patients. Keywords: 6-minute walk exercise, mitral regurgitation, heart failure, non-ischemic cardiomyopathy
... Several studies have showed high feasibility and reproducibility for VCA assessment at rest (26). VCA at rest has high sensitivity while its exercise-induced increase has high specificity for identifying patients with the adverse clinical outcome (27). Also, the assessments of VCA seems to be highly sensitive to track exercise-induced changes in functional MR, while the PISA method underestimated EROA both at rest and during exercise. ...
... This permits a comprehensive evaluation of cardiac anatomy and function from a single acquisition. [17][18][19][20] Several studies have demonstrated the concordance aravalvular leaks (PVLs: abnormal communication between the cardiovascular chambers adjacent to a prosthetic valve) are a potential complication of surgical valve replacement procedures. 1 The incidence of mitral PVLs, including small non-significant jets, is estimated to be as high as 17% and is more frequent when there is severe annular calcification, or following endocarditis. 2-4 PVL is most commonly observed with mechanical valves, followed by bioprosthetic valves. ...
Article
Full-text available
Background: Mitral paravalvular leak (PVL) is a potential complication of surgical valve replacement procedures. Real-time 3D transesophageal echocardiography (RT-3DTEE) has emerged as an efficient tool for providing essential information about the anatomy of mitral PVLs compared with 2DTEE findings. The purpose of this study was to evaluate the utility of RT-3DTEE in the assessment of mitral PVLs.Methods and Results:The 3D characteristics of PVLs were recorded and compared with 2D findings. We included 34 consecutive patients with clinical suspicion of mitral PVL in the study. Mitral PVLs were detected in 26 patients (76%); 26 PVLs were identified by 2DTEE and 37 by RT-3DTEE. Moderate or severe mitral regurgitation was present in 23 patients (88%). The most common PVL locations were the septal and posterior regions. The median PVL size measured by RT-3DTEE was 7 mm long×4 mm wide. The median vena contracta of defect measured by 2DTEE and RT-3DTEE was 5 mm and 4 mm, respectively. The median effective regurgitant orifice area of defect measured by RT-3DTEE was 0.36 cm(2). The defect types were "oval" (54%), "round" (35%), "crescentic" (8%) and highly irregular (3%). Conclusions: Compared with 2DTEE, RT-3DTEE provided detailed descriptions of the number, location, size and morphology of PVLs, which is essential for planning and guiding the potential corrective techniques.
Article
Full-text available
Objective: The right ventricle myocardial infarction (RVMI) is one of the leading reasons for right ventricle(RV) dysfunction. RVMI occurs in 20-50% of inferior infarctions. Echocardiography was applied to study RV involvement and proximal right coronary artery (RCA) occlusion in individuals with acute inferior MI. The objective of this study was to investigate if pulmonary annulus motion velocity (PAMVUT) levels in individuals with acute inferior myocardial infarction were linked to proximal RCA lesions. Method: The study comprised 50 people who had been diagnosed with acute inferior myocardial infarction and had culprit lesions in the right coronary artery. The RCA occlusion in Group A was proximal to the right ventricular branch, while the RCA occlusion in Group B was distant to the RV branch. The PAMVUT was tested, as well as other echocardiographic parameters. Results: In terms of metrics indicating right ventricular function, there were substantial disparities between the groups. A favorable association was established in the univariate correlation analysis between PAMVUT and RV TAPSE, with FAC, and with St.PAMVUT was identified as an independent predictor of proximal RCA occlusion in a multivariate logistic regression test. In the ROC analysis, PAMVUT
Article
Background: Magnetic resonance imaging (MRI) is an accurate method for the quantitative assessment of organic mitral regurgitation (OMR). The aim of the present study was to compare the discriminative power of MRI quantification and the recommended Doppler echocardiography (ECHO)-derived integrative approach to identify asymptomatic patients with OMR and adverse outcome. Methods: The study population consisted of 258 asymptomatic patients (63±14 years, 60% men) with preserved left ventricular ejection fraction (>60%) and chronic moderate and severe OMR (flail 25%, prolapse 75%) defined by using the ECHO-derived integrative approach. All patients underwent MRI to quantify regurgitant volume (RV) of OMR by subtracting the aortic forward flow volume from the total left ventricular stroke volume. Severe OMR was defined as RV≥60 mL. Results: Mean ECHO-derived RV was on average 17.1 mL larger than the MRI-derived RV (P<0.05). Concordant grading of OMR severity with both techniques was observed in 197 (76%) individuals with 62 (31%) patients having severe OMR (MRI SEV-ECHO SEV) and 135 (69%) patients having moderate OMR (MRI MOD-ECHO MOD). The remaining 61 (24%) individuals had discordant findings (MRI SEV-ECHO MOD or MRI MOD-ECHO SEV) between the 2 techniques. The majority of these differences in OMR classification were observed in patients with late systolic or multiple jets (both κ<0.2). Patients with eccentric jets showed moderate agreement (κ=0.53; 95% confidence interval, 0.41-0.64). In contrast, a very good agreement (κ=0.90; 95% confidence interval, 0.82-0.98) was observed in a combination of holosystolic, central, and single jet. During a median follow-up of 5.0 years (interquartile range, 3.5-6.0 years), 38 (15%) patients died and 106 (41%) either died or developed indication for mitral valve surgery. In separate Cox regression analyses, the MRI-derived left ventricular end-systolic volume index, RV, and OMR category (severe versus moderate), and the ECHO-derived OMR category were independent predictors of all-cause mortality (allP<0.05). The MRI-derived RV showed the largest area under the curve to predict mortality (0.72) or its combination with the development of indication for mitral valve surgery (0.83). Conclusions: The findings of the present study suggest that the MRI-derived assessment of OMR can better identify patients with severe OMR and adverse outcome than ECHO-derived integrative approach warranting close follow-up and perhaps, early mitral valve surgery.
Article
Full-text available
Background: We assessed whether measuring pulmonary annular motion velocity could serve as a novel method of evaluating right ventricular outflow tract (RVOT) performance in pediatric patients with heart disease.Methods and Results:Tissue Doppler-derived pulmonary annular motion velocity was determined from the parasternal long-axis view of the RVOT. Pulmonary annular velocity was measured in children (age, 5-10 years) with an atrial septal defect (ASD), pulmonary arterial hypertension (PAH), surgically repaired tetralogy of Fallot (TOF) and healthy children (control). Pulmonary annular velocity waveforms comprised systolic bimodal (s1' and s2') and diastolic e' and a' waves in all groups. The peak velocity of s1' and s2' was significantly higher in the ASD group than in the controls (15.0±2.4 vs. 11.2±2.1 and 6.0±0.9 vs. 4.4±1.2 cm/s; P<0.01 and P<0.001, respectively). The s1' and s2' peak velocities were significantly lower in the PAH group (8.5±1.2 and 3.2±0.4 cm/s; P<0.05 for both), and in the group with TOF (5.3±2.2 and 3.4±1.4 cm/s; P<0.001 and P<0.05, respectively). The peak velocity of e' was significantly decreased in the PAH and TOF, compared with the control group (6.8±1.6 and 8.2±2.9 vs. 11.9±1.9 cm/s; P<0.001 for both). Conclusions: Pulmonary annular motion velocity determined using tissue Doppler imaging is a promising method of assessing RVOT function.
Article
Full-text available
Valvular regurgitation represents an important cause of cardiovascular morbidity and mortality. Echocardiography has become the primary non-invasive imaging method for the evaluation of valvular regurgitation. The echocardiographic assessment of valvular regurgitation should integrate the quantification of the regurgitation, assessment of the valve anatomy and function, as well as the consequences of valvular disease on cardiac chambers. In clinical practice, the management of patients with valvular regurgitation thus largely integrates the results of echocardiography. It is crucial to provide standards that aim at establishing a baseline list of measurements to be performed when assessing regurgitation.
Article
Full-text available
MitraClip® therapy is a percutaneous edge-to-edge plication of the mitral leaflets, mimicking the Alfieri surgical technique. MitraClip® implantation is a safe procedure, and survival outcomes in high-surgical-risk patients are superior to historical controls. Despite these results, questions remain concerning long-term efficacy and durability. The MitraClip® device has been studied in a safety and feasibility trial in the USA, a randomized pivotal trial against surgical mitral valve repair. Moreover, MitraClip® now has over 2 years of CE-mark approval and a rapidly expanding clinical experience in Europe, primarily in patients at high risk for surgery. A dedicated multidisciplinary team is necessary, as well as thoughtful patient selection, familiarity with the technical aspects of the procedure, including transesophageal ultrasound imaging and post-procedure monitoring. Currently available clinical data and procedural steps are herein reviewed. Because the MitraClip® procedure is still relatively new, continued investigation is required to further better define the patient populations that will benefit most.
Article
Chronic ischemic mitral regurgitation (IMR) is still a significant clinical problem. It is present in 10-20% of patients with coronary artery disease and is associated with a worse prognosis after myocardial infarction and subsequent revascularization. Currently, coronary artery bypass grafting combined with restrictive annuloplasty is the most commonly performed surgical procedure, although novel approaches have been used in limited numbers with varying degrees of success. The purpose of this review is to clarify the rationale for the surgical techniques applicable to IMR. In order to do so, the condition will be defined and the evolution of classic or traditional surgical approaches to repairing or replacing the mitral valve in the setting of IMR will be described. Finally, novel approaches to the repair of the ischemic mitral valve will be considered.
Article
Significant mitral regurgitation (MR) is estimated to afflict >2 million Americans and is anticipated to increase in prevalence as the baby boomer population ages.1 Approximately 10% of people ≥75 years of age have significant MR,1 and these patients have decreased survival regardless of whether MR is caused by a primary leaflet abnormality2 or is secondary to left ventricular (LV) dysfunction.3–7 The primary clinical tool for evaluation of the mechanism and severity of MR is echocardiography; however, many patients referred to surgical centers for severe MR by echocardiography have only mild or moderate MR on quantitative evaluation.8 Because surgery is only indicated in patients with severe MR,9,10 it is imperative to quantify MR severity accurately. In 2003, the American Society of Echocardiography (ASE) and the European Association of Echocardiography (EAE) jointly published recommendations for quantification of valvular regurgitation.11 In 2010, the EAE published an updated guideline document.12 The present review aims to summarize those recommendations and to incorporate new data regarding the use of 3-dimensional (3D) echocardiographic parameters to determine MR severity. First, a theoretical framework for understanding the quantitative determinants of MR severity will be presented. Then, the practical application of various techniques for assessment of MR severity will be discussed, including their strengths and weaknesses. New evidence regarding the use of 3D echocardiography to quantify MR severity will be presented. As with the ASE and EAE guidelines, we will emphasize the importance of an integrative approach. Integration of multiple quantitative parameters, including newly available 3D parameters, is needed for the final determination of MR severity. Finally, the role of cine magnetic resonance imaging (CMR) and cardiac catheterization in quantitation of MR will be discussed. As described by Levine and Gaasch,13 the Gorlin hydraulic orifice equation can …
Article
Accurate quantification of mitral regurgitation (MR) is important for patient treatment and prognosis. Three-dimensional echocardiography allows for the direct measure of the regurgitant orifice area (ROA) by 3D-guided planimetry of the vena contracta area (VCA). We aimed to (1) establish 3D VCA ranges and cutoff values for MR grading, using the American Society of Echocardiography-recommended 2D integrative method as a reference, and (2) compare 2D and 3D methods of ROA to establish a common calibration for MR grading. Eighty-three patients with at least mild MR underwent 2D and 3D echocardiography. Direct planimetry of VCA was performed by 3D echocardiography. Two-dimensional quantification of MR included 2D ROA by proximal isovelocity surface area (PISA) method, vena contracta width, and ratio of jet area to left atrial area. There were significant differences in 3D VCA among patients with different MR grades. As assessed by receiver operating characteristic analysis, 3D VCA at a best cutoff value of 0.41 cm(2) yielded 97% of sensitivity and 82% of specificity to differentiate moderate from severe MR. There was significant difference between 2D ROA and 3D VCA in patients with functional MR, resulting in an underestimation of ROA by 2D PISA method by 27% as compared with 3D VCA. Multivariable regression analysis showed functional MR as etiology was the only predictor of underestimation of ROA by the 2D PISA method. Three-dimensional VCA provides a single, directly visualized, and reliable measurement of ROA, which classifies MR severity comparable to current clinical practice using the American Society of Echocardiography-recommended 2D integrative method. The 3D VCA method improves accuracy of MR grading compared with the 2D PISA method by eliminating geometric and flow assumptions, allowing for uniform clinical grading cutoffs and ranges that apply regardless of etiology and orifice shape.
Article
quantification of mitral regurgitation severity with 2-dimensional (2D) imaging techniques remains challenging. The present study compared the accuracy of 2D transesophageal echocardiography (TEE) and 3-dimensional (3D) TEE for quantification of mitral regurgitation, using MRI as the reference method. two-dimensional and 3D TEE and cardiac MRI were performed in 30 patients with mitral regurgitation. Mitral effective regurgitant orifice area (EROA) and regurgitant volume (Rvol) were estimated with 2D and 3D TEE. With 3D TEE, EROA was calculated using planimetry of the color Doppler flow from en face views and Rvol was derived by multiplying the EROA by the velocity time integral of the regurgitant jet. Finally, using MRI, mitral Rvol was quantified by subtracting the aortic flow volume from left ventricular stroke volume. Compared with 3D TEE, 2D TEE underestimated the EROA by a mean of 0.13 cm(2). In addition, 2D TEE underestimated the Rvol by 21.6% when compared with 3D TEE and by 21.3% when compared with MRI. In contrast, 3D TEE underestimated the Rvol by only 1.2% when compared with MRI. Finally, one third of the patients in grade 1 and ≥50% of the patients in grade 2 and 3, as assessed with 2D TEE, would have been upgraded to a more severe grade, based on the 3D TEE and MRI measurements. quantification of mitral EROA and Rvol with 3D TEE is feasible and accurate as compared with MRI and results in less underestimation of the Rvol as compared with 2D TEE.
Article
The aim of this study was to evaluate feasibility and accuracy of real-time 3-dimensional (3D) echocardiography for quantification of mitral regurgitation (MR), in a head-to-head comparison with velocity-encoded cardiac magnetic resonance (VE-CMR). Accurate grading of MR severity is crucial for appropriate patient management but remains challenging. VE-CMR with 3D three-directional acquisition has been recently proposed as the reference method. A total of 64 patients with functional MR were included. A VE-CMR acquisition was applied to quantify mitral regurgitant volume (Rvol). Color Doppler 3D echocardiography was applied for direct measurement, in "en face" view, of mitral effective regurgitant orifice area (EROA); Rvol was subsequently calculated as EROA multiplied by the velocity-time integral of the regurgitant jet on the continuous-wave Doppler. To assess the relative potential error of the conventional approach, color Doppler 2-dimensional (2D) echocardiography was performed: vena contracta width was measured in the 4-chamber view and EROA calculated as circular (EROA-4CH); EROA was also calculated as elliptical (EROA-elliptical), measuring vena contracta also in the 2-chamber view. From these 2D measurements of EROA, the Rvols were also calculated. The EROA measured by 3D echocardiography was significantly higher than EROA-4CH (p < 0.001) and EROA-elliptical (p < 0.001), with a significant bias between these measurements (0.10 cm(2) and 0.06 cm(2), respectively). Rvol measured by 3D echocardiography showed excellent correlation with Rvol measured by CMR (r = 0.94), without a significant difference between these techniques (mean difference = -0.08 ml/beat). Conversely, 2D echocardiographic approach from the 4-chamber view significantly underestimated Rvol (p = 0.006) as compared with CMR (mean difference = 2.9 ml/beat). The 2D elliptical approach demonstrated a better agreement with CMR (mean difference = -1.6 ml/beat, p = 0.04). Quantification of EROA and Rvol of functional MR with 3D echocardiography is feasible and accurate as compared with VE-CMR; the currently recommended 2D echocardiographic approach significantly underestimates both EROA and Rvol.